CDNA
CareDx, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Strong buy
+67/100
Last price
63.01
▼ 6.84 (9.79%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
69.85
Prev close
69.85
Day high
72.51
Day low
63.74
Volume
2.56M
Market cap
$3.30B
P/E (TTM)
30.67
52W range
13.95 – 72.51
Day trading desk
Gap from prior close
+0.00%
Prior close 69.85
VWAP
64.93
-2.96% from price
Relative volume
3.57×
Unusually busy
Session range
15.81%
62.61 – 72.51
Position in range
4%
Near session low
ATR (14D)
3.79
6.02% of price
Prior day high
70.75
PDH
Prior day low
66.17
PDL
Bid / ask spread
—
Quote not published
Session volume
4.51M
Avg 1.26M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.36%
-2.3%
1M
+25.37%
+24.2%
3M
+131.54%
+127.0%
6M
+261.01%
+242.8%
YTD
+238.59%
+224.3%
1Y
+319.95%
+303.5%
3Y
+811.29%
+729.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CDNA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-38.51K
Net selling
Buy transactions
13
311.81K shares
Sell transactions
14
350.33K shares
Net transactions
+27
Buys less sells
Sell : buy shares
1.1 : 1
Mixed
Insider-held shares
1.62M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 2, 26 | GOLDBERG MICHAEL D Director |
STOCK | 588 | $0 | Direct |
| Aug 5, 26 | BICKERSTAFF GEORGE W III Director |
SELL | 20.00K | $925.70K | Direct |
| Aug 5, 26 | NOVACK JEFFREY ADAM General Counsel |
SELL | 2.69K | $124.35K | Direct |
| Aug 4, 26 | COURNOYER CHRISTINE M Director |
SELL | 16.00K | $750.97K | Direct |
| Aug 4, 26 | GOLDBERG MICHAEL D Director |
SELL | 44.70K | $2.10M | Direct |
| Jul 16, 26 | HANNA JOHN WALTER JR Chief Executive Officer |
SELL | 118.00K | $4.46M | Direct |
| Jul 16, 26 | VALANTINE HANNAH A. Director |
SELL | 28.78K | $1.04M | Direct |
| Jul 16, 26 | HANNA JOHN WALTER JR Chief Executive Officer |
CONVERSION | 118.00K | $967.60K | Direct |
| Jul 16, 26 | VALANTINE HANNAH A. Director |
CONVERSION | 28.78K | $424.89K | Direct |
| Jul 2, 26 | GOLDBERG MICHAEL D Director |
STOCK | 1.75K | $0 | Direct |
| Jun 29, 26 | HANNA JOHN WALTER JR Chief Executive Officer |
SELL | 40.00K | $1.17M | Direct |
| Jun 29, 26 | HANNA JOHN WALTER JR Chief Executive Officer |
CONVERSION | 70.00K | $574.00K | Direct |
| Jun 15, 26 | HANNA JOHN WALTER JR Chief Executive Officer |
SELL | 17.68K | $424.88K | Direct |
| Jun 15, 26 | VALANTINE HANNAH A. Director |
SELL | 12.10K | $279.73K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BICKERSTAFF GEORGE W III |
Director | 134.06K | Sale |
COHEN FREDERICK E. M.D. PH.D. |
Director | 165.06K | Stock Award(Grant) |
GOLDBERG MICHAEL D |
Director | 153.37K | Stock Award(Grant) |
HANNA JOHN WALTER JR |
Chief Executive Officer | 653.45K | Sale |
JAIN ABHISHEK |
Chief Financial Officer | 337.42K | Sale |
KENNEDY KEITH S |
Chief Operating Officer | 221.55K | Stock Award(Grant) |
MAAG PETER |
Director | 308.85K | Sale |
MENG JESSICA |
Officer | 176.78K | Stock Award(Grant) |
NOVACK JEFFREY ADAM |
General Counsel | 106.08K | Sale |
SMITH NATHAN |
Chief Financial Officer | 79.02K | Stock Award(Grant) |
Fundamentals
Market cap$3.30B
Enterprise value$2.95B
Revenue (TTM)$458.09M
Gross profit$323.33M
EBITDA$12.43M
Net income$111.01M
EPS (TTM)$2.08
Free cash flow$112.16M
Total cash$373.64M
Total debt$19.25M
Book value / share$8.27
Shares outstanding51.73M
Float49.45M
Short % of float12.40%
Dividend yield0.00%
Beta (5Y)2.38
Valuation & profitability ratios
Trailing P/E30.67
Forward P/E49.45
PEG ratio—
Price / sales—
Price / book7.72
EV / revenue6.43
EV / EBITDA236.93
Gross margin70.58%
Operating margin0.19%
Profit margin24.23%
Return on equity29.49%
Return on assets-0.25%
Debt / equity4.52
Current ratio4.58
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $379.81M | $333.79M | $280.32M | $321.79M | +13.8% |
| Operating revenue | $379.81M | $333.79M | $280.32M | $321.79M | +13.8% |
| Cost of revenue | $123.24M | $109.70M | $102.07M | $112.21M | +12.3% |
| Gross profit | $256.57M | $224.09M | $178.26M | $209.58M | +14.5% |
| Research & development | $71.43M | $72.51M | $82.42M | $90.39M | -1.5% |
| Selling, general & admin | $210.21M | $207.11M | $202.90M | $196.42M | +1.5% |
| Total operating expense | $281.64M | $279.62M | $285.32M | $286.81M | +0.7% |
| Operating income | -$25.07M | -$55.53M | -$107.06M | -$77.23M | +54.9% |
| Net interest income | $9.17M | $11.77M | $11.87M | $3.76M | -22.0% |
| Pre-tax income | -$21.08M | $52.86M | -$190.14M | -$76.23M | -139.9% |
| Tax provision | $271.00K | $310.00K | $141.00K | $379.00K | -12.6% |
| Net income | -$21.35M | $52.55M | -$190.28M | -$76.61M | -140.6% |
| Net income to common | -$21.35M | $52.55M | -$190.28M | -$76.61M | -140.6% |
| Basic EPS | -0.40 | 1.00 | -3.54 | -1.44 | -140.0% |
| Diluted EPS | -0.40 | 0.93 | -3.54 | -1.44 | -143.0% |
| EBIT | -$25.07M | -$55.53M | -$107.06M | -$77.23M | +54.9% |
| EBITDA | -$4.66M | -$35.78M | -$87.24M | -$61.22M | +87.0% |
| Basic shares | 53.29M | 52.77M | 53.76M | 53.32M | +1.0% |
| Diluted shares | 53.29M | 56.62M | 53.76M | 53.32M | -5.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $65.43M | $114.69M | $82.20M | $89.92M | -43.0% |
| Cash & short-term investments | $177.21M | $260.65M | $235.42M | $293.09M | -32.0% |
| Accounts receivable | $42.63M | $64.61M | $51.06M | $66.31M | -34.0% |
| Inventory | $26.70M | $19.50M | $19.47M | $19.23M | +36.9% |
| Total current assets | $257.13M | $351.83M | $313.71M | $387.85M | -26.9% |
| Property, plant & equipment | $55.73M | $57.89M | $65.14M | $70.22M | -3.7% |
| Goodwill & intangibles | $72.30M | $78.52M | $86.04M | $80.57M | -7.9% |
| Total assets | $413.23M | $491.05M | $466.83M | $542.99M | -15.8% |
| Total current liabilities | $89.85M | $89.37M | $78.07M | $75.97M | +0.5% |
| Total debt | $26.19M | $28.37M | $34.22M | $39.00M | -7.7% |
| Total liabilities | $110.13M | $112.62M | $205.50M | $112.08M | -2.2% |
| Retained earnings | -$735.36M | -$626.24M | -$678.27M | -$460.44M | -17.4% |
| Shareholder equity | $303.10M | $378.43M | $261.33M | $430.91M | -19.9% |
| Working capital | $167.28M | $262.46M | $235.64M | $311.87M | -36.3% |
| Net tangible assets | $230.81M | $299.91M | $175.29M | $350.34M | -23.0% |
| Shares issued | 50.92M | 54.77M | 51.50M | 53.53M | -7.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$21.35M | $52.55M | -$190.28M | -$76.61M | -140.6% |
| Depreciation & amortisation | $20.42M | $19.76M | $19.82M | $16.01M | +3.3% |
| Stock-based compensation | $34.86M | $66.41M | $49.09M | $46.55M | -47.5% |
| Change in working capital | $3.81M | -$102.12M | $106.03M | -$14.22M | +103.7% |
| Operating cash flow | $42.03M | $38.05M | -$18.39M | -$25.24M | +10.5% |
| Capital expenditure | -$6.59M | -$6.48M | -$9.24M | -$24.33M | -1.6% |
| Investing cash flow | $2.16M | -$483.00K | $40.45M | -$228.50M | +546.8% |
| Share buybacks | -$87.77M | -$522.00K | -$27.54M | -$642.00K | -16,713.8% |
| Financing cash flow | -$93.39M | -$5.61M | -$29.61M | -$4.54M | -1,566.0% |
| Free cash flow | $35.44M | $31.56M | -$27.63M | -$49.57M | +12.3% |
| End cash position | $65.98M | $115.27M | $82.78M | $90.44M | -42.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $131.95M | $117.70M | $108.39M | $100.06M | $86.68M | +12.1% |
| Operating revenue | $131.95M | $117.70M | $108.39M | $100.06M | $86.68M | +12.1% |
| Cost of revenue | $34.97M | $33.63M | $35.51M | $30.65M | $28.66M | +4.0% |
| Gross profit | $96.98M | $84.07M | $72.87M | $69.40M | $58.02M | +15.4% |
| Research & development | $22.38M | $21.42M | $19.31M | $16.77M | $16.83M | +4.5% |
| Selling, general & admin | $74.35M | $60.86M | $59.61M | $52.88M | $51.96M | +22.2% |
| Total operating expense | $96.72M | $82.27M | $78.91M | $69.65M | $68.79M | +17.6% |
| Operating income | $257.00K | $1.80M | -$6.04M | -$246.00K | -$10.77M | -85.7% |
| Net interest income | $1.74M | $1.91M | $2.01M | $2.01M | $2.36M | -9.1% |
| Pre-tax income | $114.52M | $2.78M | -$3.76M | $1.66M | -$8.69M | +4,023.8% |
| Tax provision | $3.88M | -$32.00K | $345.00K | -$15.00K | -$117.00K | +12,231.3% |
| Net income | $110.64M | $2.81M | -$4.11M | $1.68M | -$8.57M | +3,838.6% |
| Net income to common | $110.64M | $2.81M | -$4.11M | $1.68M | -$8.57M | +3,838.6% |
| Basic EPS | 2.15 | 0.05 | -0.08 | 0.03 | -0.16 | +4,200.0% |
| Diluted EPS | 2.07 | 0.05 | -0.08 | 0.03 | -0.16 | +4,040.0% |
| EBIT | $257.00K | $1.80M | -$6.04M | -$246.00K | -$10.77M | -85.7% |
| EBITDA | $4.30M | $7.12M | -$780.00K | $4.92M | -$5.72M | -39.5% |
| Basic shares | 51.47M | 51.15M | 51.12M | 52.51M | 54.30M | +0.6% |
| Diluted shares | 53.42M | 53.13M | 51.12M | 53.74M | 54.30M | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $373.64M | $77.92M | $65.43M | $91.44M | $68.21M | +379.5% |
| Cash & short-term investments | $373.64M | $187.18M | $177.21M | $194.22M | $186.25M | +99.6% |
| Accounts receivable | $34.38M | $44.59M | $42.63M | $47.84M | $67.36M | -22.9% |
| Inventory | $6.98M | $26.40M | $26.70M | $28.33M | $27.91M | -73.6% |
| Total current assets | $429.22M | $269.39M | $257.13M | $300.28M | $307.30M | +59.3% |
| Property, plant & equipment | $43.04M | $54.36M | $55.73M | $54.89M | $57.31M | -20.8% |
| Goodwill & intangibles | $54.52M | $72.44M | $72.30M | $73.78M | $76.37M | -24.7% |
| Total assets | $532.99M | $411.06M | $413.23M | $432.31M | $444.26M | +29.7% |
| Total current liabilities | $93.70M | $79.15M | $89.85M | $99.04M | $93.18M | +18.4% |
| Total debt | $19.25M | $24.50M | $26.19M | $27.64M | $29.12M | -21.4% |
| Total liabilities | $107.39M | $97.53M | $110.13M | $121.17M | $116.89M | +10.1% |
| Retained earnings | -$505.45M | -$732.55M | -$735.36M | -$719.05M | -$695.16M | +31.0% |
| Shareholder equity | $425.60M | $313.54M | $303.10M | $311.14M | $327.37M | +35.7% |
| Working capital | $335.52M | $190.24M | $167.28M | $201.24M | $214.12M | +76.4% |
| Net tangible assets | $371.07M | $241.10M | $230.81M | $237.36M | $251.00M | +53.9% |
| Shares issued | 51.48M | 51.27M | 50.92M | 51.41M | 53.22M | +0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $110.64M | $2.81M | -$4.11M | $1.68M | -$8.57M | — | +3,838.6% |
| Depreciation & amortisation | $4.05M | $5.32M | $5.26M | $5.16M | $5.05M | — | -23.9% |
| Stock-based compensation | $10.65M | $9.80M | $8.09M | $8.42M | $9.42M | — | +8.7% |
| Change in working capital | $17.59M | -$14.64M | $12.17M | $18.86M | $3.76M | — | +220.1% |
| Operating cash flow | $30.60M | $4.33M | $21.36M | $37.36M | $9.89M | — | +606.3% |
| Capital expenditure | -$1.86M | -$3.82M | -$1.97M | -$1.98M | -$1.01M | — | +51.3% |
| Investing cash flow | $280.59M | $11.06M | -$34.91M | $12.35M | $23.40M | — | +2,437.2% |
| Share buybacks | — | — | -$12.21M | -$25.56M | -$50.00M | $0 | — |
| Financing cash flow | -$15.50M | -$2.91M | -$12.46M | -$26.48M | -$53.81M | — | -432.4% |
| Free cash flow | $28.75M | $514.00K | $19.39M | $35.38M | $8.89M | — | +5,492.6% |
| End cash position | $374.16M | $78.47M | $65.98M | $91.99M | $68.76M | — | +376.8% |
Options analytics
Put / call volume
2.03
Put-heavy session
Put / call open interest
0.42
Positioning, not flow
Max pain
60.00
-5.9% from spot
ATM implied vol
81.1%
Nearest strike to spot
Skew (10% OTM)
+0.1%
Puts bid over calls
Call volume
69
Contracts, this expiry
Put volume
140
Contracts, this expiry
Heaviest call OI
65.00
306 contracts
Heaviest put OI
55.00
82 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.23 | 0.37 | +59.5% |
| Mar 2026 | 0.13 | 0.34 | +161.5% |
| Dec 2025 | 0.23 | 0.12 | -47.1% |
| Sep 2025 | 0.14 | 0.28 | +97.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.26 | 6 | $121.95M | +21.9% |
| Next quarter | 0.23 | 6 | $123.51M | +13.9% |
| Current year | 1.20 | 6 | $495.13M | +30.4% |
| Next year | 1.29 | 6 | $525.97M | +6.2% |
Analyst targets & ownership
Mean target$58.83
High target$74.00
Low target$46.00
Implied upside-6.63%
Analyst count6
ConsensusBUY
Strong buy / Buy0 / 5
Hold2
Sell / Strong sell0 / 0
Held by insiders3.13%
Held by institutions104.05%
Institutions holding330
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
64.00
-1.55% from price
SMA 20
58.39
+9.25% from price
SMA 50
51.46
+23.97% from price
SMA 100
39.18
+60.81% from price
SMA 200
29.23
+118.22% from price
EMA 12
62.86
+0.25% from price
EMA 26
57.98
+8.68% from price
EMA 50
51.81
+21.62% from price
RSI (14)
63.3
Neutral
MACD (12,26,9)
4.88
Hist 0.55
ATR (14)
3.79
5.94% of price
Realised vol 30D
57.1%
Annualised
Bollinger upper
71.22
20, 2σ
Bollinger lower
45.56
20, 2σ
50 / 200 cross
Golden
51.46 vs 29.23
Trend bias
Above 200
+118.22%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.32
More volatile than market
Correlation to SPY
0.24
Largely independent
Realised vol 30D
57.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-23.6%
Peak to trough
Max drawdown 5Y
-93.3%
Peak to trough
ATR 14
3.79
5.94% of price
Beta (reported)
2.38
5Y monthly, from filing
Short interest
Shares short
6.30M
Prior 5.79M
Change vs prior
+8.8%
Shorts adding
% of float
12.40%
Elevated
% of shares out
12.17%
Against total outstanding
Days to cover
5.6
Crowded exit
Float
49.45M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 24, 26 | BTIG | MAINTAINED | Buy | Buy |
| Sep 2, 26 | Canaccord Genuity | INITIATED | — | Buy |
| Aug 6, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 31, 26 | HC Wainwright & Co. | MAINTAINED | Neutral | Neutral |
| Jul 16, 26 | BTIG | MAINTAINED | Buy | Buy |
| Apr 29, 26 | BTIG | MAINTAINED | Buy | Buy |
| Feb 26, 26 | BTIG | MAINTAINED | Buy | Buy |
| Feb 25, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Dec 15, 25 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Nov 6, 25 | BTIG | MAINTAINED | Buy | Buy |
| Sep 23, 25 | BTIG | MAINTAINED | Buy | Buy |
| Sep 12, 25 | BTIG | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K/A · 2026-09-16
Corporate Changes & Voting Matters
8-K · 2026-07-30
Corporate Changes & Voting Matters
8-K · 2026-07-07
Corporate Changes & Voting Matters
8-K · 2026-06-15
Proxy Statements
DEFA14A · 2026-06-05
Periodic Financial Reports
10-Q · 2026-04-28
Proxy Statements
DEF 14A · 2026-04-27
Corporate Changes & Voting Matters
8-K/A · 2026-04-23
Headlines
Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks
Zacks · 7d ago
CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar?
Zacks · 12d ago
CareDx +14% on Fresh $74 Analyst Price Target
TIKR · 12d ago
Zacks.com featured highlights include CareDx, Ciena, Celestica, Materion and MACOM Technology Solutions
Zacks · 13d ago
5 Top-Ranked High-Efficiency Stocks With Strong Profit Potential
Zacks · 14d ago
4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate Hike
Zacks · 23d ago
Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks
Zacks · 28d ago
Are Medical Stocks Lagging CareDx (CDNA) This Year?
Zacks · 29d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.